# Intensity Therapeutics, Inc.: Form 8-K, filed Jun 16, 2026

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 16:15 ET
- Period: 2026-06-16
- Accession: 0001567264-26-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/intensity-20260616.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000156726426000049/intensity-20260616.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001567264-26-000049. Last ingested by Listed: Nov 5, 2026, 12:12 ET. No prices; not investment advice.
